View the HOVID SULBACYN FOR INJECTION 1.5 G registration information details.
Back to drug list
ItemsDrug Registration information
ID320
No320
Brand NameHOVID SULBACYN FOR INJECTION 1.5 G
IngredientsAMPICILLIN SODIUM EQ.TO AMPICILLIN 1 G AND SULBACTAM SODIUM EQ.TO SULBACTAM 0.5 G
Dosage FormPOWDER FOR INJECTION
Primary PackagingVIAL
Storage
Shelf Life3 YEARS
Pack Size1.5 G/VIAL, BOX OF 1'S, 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsSKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY BETA-LACTAMASE PRODUCING STRAINS OF STAPHYLOCOCCUS AUREUS, E.COLI. KLEPSIELLA SPP. (INCLUDING K.PNEUMONIAE), PROTEUS MIRABILIS, BACTEROIDES FRAGILIS, ENTEROBACTER SPP., AND ACINETOBACTER CALCOACETICUS. INTRA-ABDOMINAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, KLEPSIELLA SPP, (INCLUDING K.PNEUMONIAE), BACTEROIDES SPP. (INCLUDING B.FRAGILIS), AND ENTEROBACTER SPP. GYNECOLOGICAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, BACTEROIDES SPP. (INCLUDING B.FRAGILIS).
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE POWDER
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerREYOUNG PHARMACEUTICAL CO., LTD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No06 I 5540/23
FDD Registration Date26/06/2023
Expiry Date25/06/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA